Civica is partnering with healthcare systems to ensure that generic drugs are affordable and available as soon as possible.
We are partnering with hospitals and healthcare systems to (1) prioritize production of generic drugs and (2) purchase Civica generic drugs, based on hospital systems’ clinical needs.
We are creating market stability by procuring or manufacturing the products required by our hospital systems
We are guaranteeing volumes for our hospitals and health system partners for each drug we manufacture
Civica is focusing on bringing value — in supply, quality, and price — to the market
We are establishing long-term partnerships that will allow us to guarantee predictable, long-term supply
We are providing our suppliers with long-term, predictable volumes
We are working with trusted, FDA-approved manufacturers with high-quality track records. We are embedding a collaborative, rigorous quality assurance process with each partner and will have a single price point for each drug, regardless of health system size
We are assuring that our prices are transparent and competitive
Civica is serving as a check in the generic manufacturing industry
We are fixing broken markets by applying for Abbreviated New Drug Applications (ANDA) for each drug we manufacture
We are having the R&D expertise necessary to enter identified drug markets and develop medications that our patients need
We are partnering with our governmental and regulatory agencies to assure we are working together in a way that benefits our patients